Table 1. Patient characteristics in the TCGA cohort.
| Total | % | |||
|---|---|---|---|---|
| Age (mean ± SD, n = 372) | 59.47 ± 13.49 | - | ||
| Overall survival_months (mean ± SD, n = 372) | 26.62 ± 24.12 | - | ||
| Sex (n = 372) |
Male | 251 | 67.5 | |
| Female | 121 | 32.5 | ||
| AJCC stage (n = 372) |
I | 172 | 46.2 | |
| II | 87 | 23.4 | ||
| III | 85 | 22.8 | ||
| IV | 6 | 1.6 | ||
| Unknown | 22 | 5.9 | ||
| Race (n = 372) |
White | 185 | 49.7 | |
| Asian | 158 | 42.5 | ||
| Black or American | 17 | 4.6 | ||
| American Indian or Alaska native | 2 | 0.5 | ||
| Unknown | 10 | 2.7 | ||
| HistologicalDiagnosis(n = 372) | Hepatocellular carcinoma | 362 | 97.3 | |
| Hepatocholangiocarcinoma (mixed) | 7 | 1.9 | ||
| Fibrolamellar carcinoma | 3 | 0.8 | ||
| Risk factors | Alcohol consumption | Alone | 68 | 58.1 |
| Hepa B | 20 | 17.1 | ||
| Hepa C | 14 | 12.0 | ||
| Hepa B + C | 3 | 2.6 | ||
| Others | 12 | 10.3 | ||
| Hepa B | Alone | 76 | 93.8 | |
| Hepa C | 3 | 3.7 | ||
| Others | 2 | 2.5 | ||
| Hepa C | Alone | 32 | 97.0 | |
| Others | 1 | 3.0 | ||
| Others alone | 30 | - | ||
| No primary risk factors | 91 | - | ||